Perhaps - but amgen already have the market.
Imagine how Amgen's shareholders would feel in 3 years when another one of their revenue streams flounders due to the inaction of management after being publicly called out by a relatively unknown asx bio. It's worth noting that carfilzomib's revenue has increased recently due to combination treatment with Darzalex (J&J).
Do we know anyone from J&J?
General Comments / Chat, page-4984
-
-
- There are more pages in this discussion • 6,892 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.55 |
Change
-0.060(3.74%) |
Mkt cap ! $261.6M |
Open | High | Low | Value | Volume |
$1.62 | $1.62 | $1.51 | $225.0K | 145.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | $1.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.55 | 1166 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | 1.540 |
2 | 30121 | 1.535 |
1 | 700 | 1.520 |
1 | 3311 | 1.510 |
2 | 7320 | 1.505 |
Price($) | Vol. | No. |
---|---|---|
1.550 | 1166 | 2 |
1.560 | 1018 | 1 |
1.570 | 1 | 1 |
1.575 | 608 | 1 |
1.585 | 757 | 1 |
Last trade - 14.29pm 09/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online